Wockhardt's Q4 FY 2025-26 Quarterly Results

Result Summary

• Wockhardt Ltd reported a 10.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 33.2%.
• Its expenses for the quarter were up by 0.8% QoQ and 8.1% YoY.
• The net profit increased 168.9% QoQ and decreased 464.4% YoY.
• The earnings per share (EPS) of Wockhardt Ltd stood at 10.22 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Wockhardt Ltd is a global pharmaceutical and biotechnology company headquartered in India. The company is known for its manufacturing and marketing of pharmaceutical and biopharmaceutical formulations, vaccines, and nutraceuticals. It operates in several therapeutic areas, including anti-infectives, cardiology, dermatology, neurology, and respiratory. Wockhardt has a significant presence in both domestic and international markets, focusing on research and development to innovate in new drug delivery systems. In recent years, the company has been engaged in expanding its global footprint and enhancing its product portfolio to meet the needs of emerging markets.

Revenue

In the fourth quarter of fiscal year 2026, Wockhardt Ltd reported a total income of ₹1010.00 crores. This reflects a quarter-over-quarter (QoQ) increase of 10.6% from ₹913.00 crores in the third quarter of fiscal year 2026. Year-over-year (YoY), there was a substantial growth of 33.2%, up from ₹758.00 crores in the fourth quarter of fiscal year 2025. These figures indicate a strong upward trajectory in the company's revenue, showcasing its ability to enhance its top-line performance over the periods considered.

Profitability

For the fourth quarter of fiscal year 2026, Wockhardt Ltd achieved a profit before tax of ₹189.00 crores, marking a significant improvement from ₹67.00 crores in the previous quarter, an increase of 182.1%. Compared to the same quarter in the previous year, when the company recorded a loss of ₹22.00 crores, this represents a notable turnaround. The company incurred a tax expense of ₹25.00 crores in Q4FY26, a rise from ₹6.00 crores in Q3FY26, and a slight increase from ₹23.00 crores in Q4FY25. Consequently, the profit after tax for Q4FY26 stood at ₹164.00 crores, a substantial increase from ₹61.00 crores in Q3FY26 and a turnaround from a loss of ₹45.00 crores in Q4FY25.

Operating Metrics

Earnings per share (EPS) for Wockhardt Ltd in the fourth quarter of fiscal year 2026 was reported at ₹10.22. This represents a considerable increase from ₹3.61 in the third quarter of fiscal year 2026, amounting to a 183.1% growth QoQ. Compared to the negative EPS of ₹-1.57 in the fourth quarter of fiscal year 2025, there is a significant improvement YoY. This reflects the company's enhanced profitability and efficiency in generating earnings for its shareholders during the analyzed period. Total expenses for Q4FY26 were ₹843.00 crores, showing a minimal QoQ increase of 0.8% from ₹836.00 crores in Q3FY26 and an 8.1% increase YoY from ₹780.00 crores in Q4FY25. This indicates a controlled rise in expenses compared to the increase in revenue and profitability.